Literature DB >> 8873636

Neuroimmune mechanisms in health and disease: 2. Disease.

H Anisman1, M G Baines, I Berczi, C N Bernstein, M G Blennerhassett, R M Gorczynski, A H Greenberg, F T Kisil, R D Mathison, E Nagy, D M Nance, M H Perdue, D K Pomerantz, E R Sabbadini, A Stanisz, R J Warrington.   

Abstract

In the second part of their article on the emerging field of neuroimmunology, the authors present an overview of the role of neuroimmune mechanisms in defence against infectious diseases and in immune disorders. During acute febrile illness, immune-derived cytokines initiate an acute phase response, which is characterized by fever, inactivity, fatigue, anorexia and catabolism. Profound neuroendocrine and metabolic changes take place: acute phase proteins are produced in the liver, bone marrow function and the metabolic activity of leukocytes are greatly increased, and specific immune reactivity is suppressed. Defects in regulatory processes, which are fundamental to immune disorders and inflammatory diseases, may lie in the immune system, the neuro endocrine system or both. Defects in the hypothalamus-pituitary-adrenal axis have been observed in autoimmune and rheumatic diseases, chronic inflammatory disease, chronic fatigue syndrome and fibromyalgia. Prolactin levels are often elevated in patients with systemic lupus erythematosus and other autoimmune diseases, whereas the bioactivity of prolactin is decreased in patients with rheumatoid arthritis. Levels of sex hormones and thyroid hormone are decreased during severe inflammatory disease. Defective neural regulation of inflammation likely plays a pathogenic role in allergy and asthma, in the symmetrical form of rheumatoid arthritis and in gastrointestinal inflammatory disease. A better understanding of neuroimmunoregulation holds the promise of new approaches to the treatment of immune and inflammatory diseases with the use of hormones, neurotransmitters, neuropeptides and drugs that modulate these newly recognized immune regulators.

Entities:  

Mesh:

Year:  1996        PMID: 8873636      PMCID: PMC1335357     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  33 in total

1.  Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses.

Authors:  S K Sundar; M A Cierpial; L S Kamaraju; S Long; S Hsieh; C Lorenz; M Aaron; J C Ritchie; J M Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 2.  Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases.

Authors:  G Wick; Y Hu; S Schwarz; G Kroemer
Journal:  Endocr Rev       Date:  1993-10       Impact factor: 19.871

3.  Endogenous iridocyclitis relieved during treatment with bromocriptine.

Authors:  L P Hedner; G Bynke
Journal:  Am J Ophthalmol       Date:  1985-10-15       Impact factor: 5.258

4.  Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis.

Authors:  G A McCain; K S Tilbe
Journal:  J Rheumatol Suppl       Date:  1989-11

5.  Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies.

Authors:  R J Soiffer; M J Robertson; C Murray; K Cochran; J Ritz
Journal:  Blood       Date:  1993-11-01       Impact factor: 22.113

6.  Prolactin deficiency in rheumatoid arthritis.

Authors:  E Nagy; I M Chalmers; F D Baragar; H G Friesen; I Berczi
Journal:  J Rheumatol       Date:  1991-11       Impact factor: 4.666

Review 7.  Pathogenesis and treatment of the anemia of chronic disease.

Authors:  S B Krantz
Journal:  Am J Med Sci       Date:  1994-05       Impact factor: 2.378

8.  Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome.

Authors:  E N Griep; J W Boersma; E R de Kloet
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

9.  Imparied interferon-gamma production by peripheral blood mononuclear cells and effects of calcitriol in pulmonary sarcoidosis.

Authors:  P Rottoli; M Muscettola; G Grasso; M G Perari; M Vagliasindi
Journal:  Sarcoidosis       Date:  1993-09

10.  Time-dependent variations of central norepinephrine and dopamine following antigen administration.

Authors:  S Zalcman; N Shanks; H Anisman
Journal:  Brain Res       Date:  1991-08-23       Impact factor: 3.252

View more
  3 in total

Review 1.  Pituitary function during severe and life-threatening illnesses.

Authors:  C Gauna; G H van den Berghe; A J van der Lely
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  The progesterone derivative dydrogesterone down-regulates neurokinin 1 receptor expression on lymphocytes, induces a Th2 skew and exerts hypoalgesic effects in mice.

Authors:  Arif Suphi Orsal; Sandra Blois; Dominika Labuz; Eva M J Peters; Martin Schaefer; Petra C Arck
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

3.  A Unique Role for Endothelial Cell Kinesin Light Chain 1, Variant 1 in Leukocyte Transendothelial Migration.

Authors:  Bita F Cyrus; William A Muller
Journal:  Am J Pathol       Date:  2016-03-17       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.